Literature DB >> 24445614

Pancreatic cancer: pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44.

Natalie J Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24445614     DOI： 10.1038/nrgastro.2014.1

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

Authors:  Mao Lin; Yuan-Ying Yuan; Shu-Peng Liu; Juan-Juan Shi; Xin-An Long; Li-Zhi Niu; Ji-Bing Chen; Qiao Li; Ke-Cheng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-10       Impact factor: 4.553

Review 2.  The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.

Authors:  Natalia Gawlik-Rzemieniewska; Ilona Bednarek
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

3.  Expression of CD44 in pancreatic cancer and its significance.

Authors:  Xiao-Ping Li; Xiao-Wei Zhang; Lei-Zhen Zheng; Wei-Jian Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery.

Authors:  Chih-Po Hsu; Li-Yu Lee; Jun-Te Hsu; Yu-Pao Hsu; Yu-Tung Wu; Shang-Yu Wang; Chun-Nan Yeh; Tse-Ching Chen; Tsann-Long Hwang
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

5.  ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis.

Authors:  Qiang Yan; Chenming Ni; Yingying Lin; Xu Sun; Zhenhua Shen; Minjie Zhang; Shuwen Han; Jiemin Shi; Jing Mao; Zhe Yang; Weilin Wang
Journal:  Front Mol Biosci       Date:  2021-12-13

6.  Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.

Authors:  Tatsuzo Mizukami; Hirofumi Kamachi; Tomoko Mitsuhashi; Yosuke Tsuruga; Yutaka Hatanaka; Toshiya Kamiyama; Yoshihiro Matsuno; Akinobu Taketomi
Journal:  BMC Cancer       Date:  2014-09-21       Impact factor: 4.430

7.  Expression and significance of CD44 and p-AKT in pancreatic head cancer.

Authors:  Li Xiaoping; Zhang Xiaowei; Zheng Leizhen; Guo Weijian
Journal:  World J Surg Oncol       Date:  2015-12-15       Impact factor: 2.754

8.  ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.

Authors:  Song Gao; Peng Wang; Yongqiang Hua; Hao Xi; Zhiqiang Meng; Te Liu; Zhen Chen; Luming Liu
Journal:  Oncotarget       Date:  2016-01-12

9.  Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging.

Authors:  Bowen Qi; Ayrianne J Crawford; Nicholas E Wojtynek; Geoffrey A Talmon; Michael A Hollingsworth; Quan P Ly; Aaron M Mohs
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.